(c) 2024 PillSync.com

Tecfidera 30Day Starter Pack

1 INDICATIONS AND USAGE TECFIDERA is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. TECFIDERA is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )

Biogen Idec Inc.


10 years ago CAPSULE GREEN BG 12 240 mg Tecfidera 30Day Starter Pack

CAPSULE GREEN BG 12 240 mg

16 HOW SUPPLIED/STORAGE AND HANDLING TECFIDERA is available as hard gelatin delayed-release capsules in two strengths containing either 120 mg or 240 mg of

DIMETHYL FUMARATE. The green and white 120 mg capsules are printed with “BG-12 120 mg” in black ink. The green 240 mg capsules are printed with “BG-12 240 mg” in black ink. TECFIDERA is available as follows: 30-day Starter Pack, (NDC 64406-007-03): 7-day bottle 120 mg capsules, quantity 14 23-day bottle 240 mg capsules, quantity 46 120 mg capsules: 7-day bottle of 14 capsules (NDC 64406-005-01) 240 mg capsules: 30-day bottle of 60 capsules (NDC 64406-006-02) Store at 15°C to 30°C (59 to 86°F). Protect the capsules from light. Store in original container.


More pills like CAPSULE BG 12 240 mg












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site